A 83-01 (Standard)
Based on 1 Customer Validation
A 83-01 (Standard) is the analytical standard of A 83-01 (HY-10432). This product is intended for research and analytical applications. A 83-01 is a potent inhibitor of TGF-β type I receptor ALK5 kinase, type I nodal receptor ALK4 and type I nodal receptor ALK7, with IC50s of 12 nM, 45 nM and 7.5 nM against the transcription induced by ALK5, ALK4 and ALK7, respectively.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 909910-43-6
- Formel: C25H19N5S
- Molecular Weight:421.52
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Reinheit & Dokumentation
-
Help & FAQs
-
HY-10431
SB-431542TGF-β Receptor Kinase Inhibitor -
HY-10182
LaduviglusibGSK-3 Inhibitor -
HY-10071
Y-27632ROCK Inhibitor -
HY-10432
A 83-01ALK4/5/7 Inhibitor -
HY-12071
LDN193189ALK2/3 Inhibitor -
HY-10432G
A 83-01 (GMP)ALK4/5/7 Inhibitor -
HY-15371R
Forskolin (Standard)Adenylate Cyclase Activator -
HY-10431G
SB-431542 (GMP)TGF-β Receptor Kinase Inhibitor -
HY-19928
VactosertibALK5 Inhibitor -
HY-13226
GalunisertibTGFβRI Inhibitor -
HY-13462
LY-364947TGFβR-I Inhibitor -
HY-13012
RepSoxTGFβR-1/ALK5 Inhibitor
Product Information
Information
Anwendung
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS. Nr. 909910-43-6
-
Appearance Solid
-
Molecular Weight 421.52
-
Formel C25H19N5S
-
Color White to off-white
-
SMILES
S=C(N1N=C(C(C2=C3C=CC=CC3=NC=C2)=C1)C4=CC=CC(C)=N4)NC5=CC=CC=C5
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Tojo M, et al. The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. Cancer Sci. 2005 Nov;96(11):791-800. [Content Brief]
[2]. Yamamura S, et al. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer. Int J Cancer. 2012 Jan 1;130(1):20-8. [Content Brief]
[3]. Taniguchi Y, et al. Enhanced antitumor efficacy of folate-linked liposomal Adriamycin with TGF-β type I receptor inhibitor. Cancer Sci. 2010 Oct;101(10):2207-13. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
A 83-01 (Standard) Related Classifications
HY-10432R Related Classifications
Powered by Bioz